TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint InhibitorsScott T. Tagawa, Petros Grivas, Cora N. Sternberg et al.|Journal of Clinical Oncology|2021Cited by 530
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY StudyAndrew J. Armstrong, Daniel J. George, Susan Halabi et al.|Journal of Clinical Oncology|2019Cited by 364
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolutionDuy Nguyen, Bishoy M. Faltas, William F. Hooper et al.|Nature|2024Cited by 51
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J. Shah, William Oh, Vaibhav G. Patel et al.|JNCI Cancer Spectrum|2022Cited by 11
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysisKentaro Ohara, Juan Miguel Mosquera, André F. Rendeiro et al.|Nature Communications|2024Cited by 11